News
AXGN
32.73
0.00%
0.00
Weekly Report: what happened at AXGN last week (1222-1226)?
Weekly Report · 2d ago
Weekly Report: what happened at AXGN last week (1215-1219)?
Weekly Report · 12/22 09:20
Analysts’ Top Healthcare Picks: AxoGen (AXGN), Irhythm Technologies (IRTC)
TipRanks · 12/18 11:20
Major AxoGen Stock Sales by Company Executives!
TipRanks · 12/18 02:02
Axogen CFO Lindsey Marie Hartley Reports Disposal of Common Shares
Reuters · 12/17 21:25
Weekly Report: what happened at AXGN last week (1208-1212)?
Weekly Report · 12/15 09:22
Axogen CEO Michael D. Dale Reports Sale of Common Shares
Reuters · 12/12 21:06
Axogen EVP and General Counsel Marc A. Began Reports Sale of Common Shares
Reuters · 12/12 21:06
AXOGEN INC <AXGN.O>: LEERINK PARTNERS RAISES TARGET PRICE TO $40 FROM $33
Reuters · 12/12 12:14
AxoGen Executives Unload Massive Stock Holdings!
TipRanks · 12/11 02:04
Axogen Chief Innovation Officer Erick Wayne DeVinney Reports Sale of Common Shares
Reuters · 12/10 22:20
Axogen Chief Marketing Officer Jens Kemp Reports Sale of Common Shares
Reuters · 12/10 22:20
Axogen Inc. Director Paul Thomas Reports Sale of Common Shares
Reuters · 12/10 22:19
Monday's ETF Movers: REMX, IHI
NASDAQ · 12/08 18:35
Weekly Report: what happened at AXGN last week (1201-1205)?
Weekly Report · 12/08 09:22
Axogen (AXGN) Price Target Increased by 18.26% to 34.58
NASDAQ · 12/06 10:20
AxoGen Approves New CFO Compensation and Agreement
TipRanks · 12/05 21:29
Axogen Inc. Raises CFO Lindsey Hartley’s Salary and Bonus Target
Reuters · 12/05 21:12
Axogen Is Maintained at Buy by Canaccord Genuity
Dow Jones · 12/05 19:21
Axogen Price Target Raised to $37.00/Share From $27.00 by Canaccord Genuity
Dow Jones · 12/05 19:21
More
Webull provides a variety of real-time AXGN stock news. You can receive the latest news about Axogen Inc through multiple platforms. This information may help you make smarter investment decisions.
About AXGN
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.